ey0018.8-6 | Important for Clinical Practice | ESPEYB18
AL Hirschberg , S Gidlof , H Falhammar , L Frisen , C Almqvist , A Nordenskjold , A Nordenstrom
ey0020.1-6 | Congenital Hypothyroidism | ESPEYB20
A Esposito , MC Vigone , M Polizzi , MG Wasniewska , A Cassio , A Mussa , R Gastaldi , R Di Mase , G Vincenzi , C Pozzi , E Peroni , C Bravaccio , D Capalbo , D Bruzzese , M Salerno
ey0015.8-11 | Clinical Trials – New Treatments | ESPEYB15
AM Isidori , MA Venneri , C Graziadio , C Simeoli , D Fiore , V Hasenmajer , E Sbardella , D Gianfrilli , C Pozza , P Pasqualetti , S Morrone , A Santoni , F Naro , A Colao , R Pivonello , A. Lenzi
ey0018.9-2 | Cancer treatment and the risk of second neoplasia | ESPEYB18
C Thomas-Teinturier , I Oliver-Petit , H Pacquement , B Fresneau , RS Allodji , C Veres , S Bolle , D Berchery , CHaddy N Demoor-Goldschmidt , I Diallo , F. cecile.teinturier@aphp.fr de Vathaire
ey0018.8-1 | Mechanism of the year: neuropeptide substance P regulates aldosterone secretion | ESPEYB18
J Wils , C Duparc , AF Cailleux , AG Lopez , C Guiheneuf , I Boutelet , HG Boyer , C Dubessy , S Cherifi , B Cauliez , F Gobet , G Defortescu , JF Menard , E Louiset , H Lefebvre
ey0018.11-9 | Review and recommendations on ROHHAD(NET) Syndrome | ESPEYB18
J Harvengt , C Gernay , M Mastouri , N Farhat , MC Lebrethon , MC Seghaye , V Bours
ey0015.5-5 | New genes and gene mutations | ESPEYB15
C Tatsi , A Gkourogianni , K Mohnike , D DeArment , S Witchel , AC Andrade , TC Markello , J Baron , O Nilsson , YH Jee
ey0019.3-15 | Paediatric thyroid cancer | ESPEYB19
E Pasqual , S Schonfeld , LM Morton , D Villoing , C Lee , de Gonzalez A Berrington , CM Kitahara
ey0017.4-7 | New perspectives | ESPEYB17
B Grenov , A Larnkjaer , R Lee , A Serena , C Molgaard , KF Michaelsen , MJ Manary
ey0017.6-21 | Transgender Medicine: Fertility | ESPEYB17
RW Persky , SM Gruschow , N Sinaii , C Carlson , JP Ginsberg , NL Dowshen